Boaz Lev, an internist and the ministry’s deputy director-general for medical affairs, has asked the six-member committee of physicians, jurists, and public officials to define the medical conditions under which physicians will be permitted to prescribe marijuana, rather than continue on an ad hoc basis. "We want to establish the general guidelines and the optimum mechanism to provide marijuana to those who need it, but also to supervise distribution so the drug is not abused for non-medicinal use."

Marijuana can provide relief from severe chronic pain, muscular spasms, nausea, and loss of appetite caused, for example, by chemotherapy or AIDS. But Lev says "we don’t want people to have to break the law to get treatment when no other drug is effective". Possession or trade in even the smallest quantities of the drug in Israel is punishable by a jail sentence.

Calls for a committee to examine the medicinal use of marijuana have been made in the last few years. In 1995, at a meeting held at the Hebrew University of Jerusalem Rafi Mechoulam, a pharmacologist and a pioneer in marijuana research, suggested that an expert committee should look at the medicinal properties of the drug.

Earlier this year, a Knesset subcommittee, chaired by MK Naomi Chazan (Meretz) strongly recommended the Health Ministry establish an expert group. The committee also suggested that the safety and efficacy of the drug be tested in clinical trials. Chazan made it clear that "we do not expect the drug to be widely prescribed, and want to make it clear that it is being considered as a totally different issue from whether it should be legalized or decriminalized" the committee said.

No change in the general policy about marijuana use is planned or expected.